[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100537939":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":24,"centralContacts":32,"locations":39,"responsibleParty":57,"collaborators":60,"id":63,"slug":64,"hasResults":65,"nctId":66,"briefTitle":67,"officialTitle":68,"acronym":69,"eligibilityCriteria":70,"healthyVolunteers":65,"sex":71,"minAge":72,"maxAge":10,"enrollmentInfo":73,"targetDuration":10,"studyType":76,"phases":10,"briefSummary":77,"conditions":78,"keywords":86,"overallStatus":41,"whyStopped":10,"lastUpdateSubmitDate":90,"lastUpdatePostDateStruct":91,"startDateStruct":94,"completionDateStruct":96,"leadSponsor":98,"locationsCount":99},{"fullName":5,"class":6},"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Patients affected by Gynecologic Cancer undergoing systemic antineoplastic treatment",null,"Study population will consist of subsequent patients prospectively enrolled at the time of prescription of a new line of systemic antineoplastic treatment for a gynecologic oncological disease, defined as ovarian, tubal, uterine, cervical, vaginal, or vulvar neoplasm",[13],"Drug: Anticoagulant",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"DRUG","Anticoagulant","Prescription of pharmacological thromboprophylaxis according to current clinical practice and international guidelines recommendation",[9],[21,22,23],"Low Molecular Weight Heparin","Apixaban","Rivaroxaban",[25,29],{"name":26,"affiliation":27,"role":28},"Roberto Pola, PhD; MD","Agostino Gemelli University Polyclinic Foundation IRCCS","PRINCIPAL_INVESTIGATOR",{"name":30,"affiliation":27,"role":31},"Paolo Santini, MD","STUDY_CHAIR",[33,37],{"name":26,"role":34,"phone":35,"phoneExt":10,"email":36},"CONTACT","+39 0630157075","roberto.pola@policlinicogemelli.it",{"name":30,"role":34,"phone":10,"phoneExt":10,"email":38},"paolo.santini@guest.policlinicogemelli.it",[40],{"facility":27,"status":41,"city":42,"state":10,"zip":43,"country":44,"countryCode":45,"cosmosGeoPoint":46,"geoPoint":51,"contacts":52},"RECRUITING","Rome","00168","Italy","IT",{"type":47,"coordinates":48},"Point",[49,50],12.51133,41.89193,{"lat":50,"lon":49},[53,54,55],{"name":26,"role":34,"phone":35,"phoneExt":10,"email":36},{"name":30,"role":34,"phone":10,"phoneExt":10,"email":38},{"name":30,"role":56,"phone":10,"phoneExt":10,"email":10},"SUB_INVESTIGATOR",{"type":28,"investigatorFullName":58,"investigatorTitle":59,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Pola Roberto","Professor",[61],{"name":62,"class":6},"Fondazione Umberto Veronesi","100537939","the-gynecological-cancer-associated-thrombosis-gyncat-study-100537939",false,"NCT06284343","The Gynecological Cancer Associated Thrombosis (GynCAT) Study","Development and Validation of a Risk Prediction Model for Venous Thromboembolism in Gynecological Cancer Patients Undergoing Systemic Antineoplastic Treatment: The Gynecological Cancer Associated Thrombosis (GynCAT) Study","GynCAT","Inclusion Criteria:\n\n* Female sex;\n* Diagnosis of gynecologic neoplasm (ovarian, tubal, uterine, cervical, vaginal, vulvar neoplasm);\n* Planned new line of systemic antineoplastic treatment;\n* Age of 18 years or older;\n* Accordance of Informed Consent.\n\nExclusion Criteria:\n\n* Pregnant or breastfeeding women;\n* Indication to receive therapeutic dose anticoagulant therapy (e.g., atrial fibrillation, mechanical heart valve);\n* Diagnosis of symptomatic VTE at the time of screening for enrollment.","FEMALE","18 Years",{"count":74,"type":75},1800,"ESTIMATED","OBSERVATIONAL","GynCAT is a prospective cohort study that will be conducted on female patients with gynecologic malignancies scheduled for systemic antineoplastic treatment, aiming at development and validation of a Risk Assessment Model (RAM) for Venous Thromboembolism (VTE) in this specific population.",[79,80,81,82,83,84,85],"Cancer-associated Thrombosis","Venous Thromboembolism","Gynecologic Cancer","Ovarian Cancer","Cervix Cancer","Endometrial Cancer","Vaginal Cancer",[87,88,89,82,85,84,81],"Thrombosis","Venous thromboembolism","Cancer","2024-09-17",{"date":92,"type":93},"2024-09-19","ACTUAL",{"date":95,"type":93},"2024-04-15",{"date":97,"type":75},"2026-09-30",{"name":5,"class":6},1]